Mass Torts

February 11, 2022

Infant Formula Manufacturers Request MDL for NEC Lawsuits

New research has revealed that cow-milk infant formulas can increase the risk of a deadly neonatal condition called necrotizing enterocolitis (NEC) in premature infants.

This has prompted a growing number of lawsuits against the manufacturers of infant formulas Similac (Abbott Laboratories) and Enfamil (Mead Johnson) by parents of premature infants who were fed with formula and developed NEC. The lawsuits allege that Abbott and Mead negligently failed to warn parents and doctors about the NEC risk their products posed for preemies.

There are currently around 60 NEC infant formula lawsuits pending in both state and federal courts around the country, but hundreds and possibly thousands more are expected to be filed in the near future. This has prompted both Abbott and Mead to request that all NEC lawsuits in federal courts be consolidated into a new MDL. In this post, we will look at the MDL requests and speculate on the most likely venue and what it might mean for the NEC litigation moving forward.

December 30, 2021

Shampoo & Conditioner Benzene Recall

by Ronald V. Miller, Jr.

Procter & Gamble issued a recall of 30 dry conditioners and shampoos because these products may contain benzene, a cancer-causing chemical P&G recalled aerosol spray products will familiar names such as Aussie, Pantene, Herbal Essence, and Waterless. dry shampoo products from Old Spice and Hair Food.

The products were made by Proctor & Gamble and distributed nationwide through online sales like Amazon and through traditional retailers.

Is this a big deal or a little deal? Is the Benzene risk real? This post talks about the recall and what it means.

October 11, 2013

Gynecomastia from Risperdal Claims

by Ronald V. Miller, Jr.

Risperdal lawsuits have have mostly been resolved as of 2024 after a global settlement was reached. We have updated this post in 2024 to talk about the Risperdal settlements and are leaving the rest of this post up for informational purposes. Our lawyers are no longer seeking new claims.

2024 Risperdal Litigation Update

The lawsuits were primarily based on allegations that Risperdal, an antipsychotic medication, led to the development of gynecomastia in boys and young men, a condition characterized by the growth of breast tissue.